<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxics</journal-id><journal-id journal-id-type="iso-abbrev">Toxics</journal-id><journal-id journal-id-type="publisher-id">toxics</journal-id><journal-title-group><journal-title>Toxics</journal-title></journal-title-group><issn pub-type="epub">2305-6304</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997890</article-id><article-id pub-id-type="pmc">PMC11860863</article-id>
<article-id pub-id-type="doi">10.3390/toxics13020073</article-id><article-id pub-id-type="publisher-id">toxics-13-00073</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of GSTM1 and GSTT1 Copy Number Variation with Chromosomal Aberrations in Nuclear Power Plant Workers Exposed to Occupational Ionizing Radiation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Joong won</given-names></name><xref rid="af1-toxics-13-00073" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Younghyun</given-names></name><xref rid="af2-toxics-13-00073" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Yang Jee</given-names></name><xref rid="af3-toxics-13-00073" ref-type="aff">3</xref><xref rid="c1-toxics-13-00073" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Jia</surname><given-names>Guang</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxics-13-00073"><label>1</label>Division of Population Health Research, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea; <email>won3@korea.kr</email></aff><aff id="af2-toxics-13-00073"><label>2</label>Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunghyang University, 22, Soonchunhyango-ro, Asan-si 31538, Republic of Korea; <email>ylee0123@sch.ac.kr</email></aff><aff id="af3-toxics-13-00073"><label>3</label>College of General Education, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 16974, Republic of Korea</aff><author-notes><corresp id="c1-toxics-13-00073"><label>*</label>Correspondence: <email>yangjee4@hanmail.net</email></corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>73</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>21</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Exposure to low-dose ionizing radiation in occupational settings raises concerns about chromosomal aberrations (CAs) and their potential impact on genomic stability. Copy number variations (CNVs), structural genomic changes, influence susceptibility to environmental stressors and radiation-induced damage. This study analyzed CAs in 180 nuclear power plant workers exposed to occupational radiation and 45 controls, stratified by GSTM1 and GSTT1 CNVs. Workers exhibited significantly higher frequencies of chromatid-type and chromosome-type aberrations, of 5.47 and 3.01 per 500 cells, respectively, compared to 3.57 and 0.64 in controls (<italic toggle="yes">p</italic> &#x0003c; 0.001 for both). In the relatively high-exposure group, chromatid-type aberrations decreased with increasing GSTM1 and GSTT1 copy numbers. For GSTM1, individuals with zero copies showed 6.37 &#x000b1; 3.47 aberrations per 500 cells, compared to 5.02 &#x000b1; 3.05 for one copy and 4.67 &#x000b1; 2.40 for two or more copies (<italic toggle="yes">p</italic> = 0.06). A similar trend was observed for GSTT1, with 6.00 &#x000b1; 3.29 aberrations per 500 cells for zero copies, 5.38 &#x000b1; 2.79 for one copy, and 4.11 &#x000b1; 4.26 for two or more copies (<italic toggle="yes">p</italic> = 0.05). Poisson regression analysis further supported these findings after adjusting for potential confounders such as age, smoking status, and alcohol intake. Workers with null genotypes exhibited a 1.36-fold increase in chromatid-type aberrations compared to those with higher copy numbers under relatively high-exposure conditions, suggesting a synergy effect between GSTM1 and GSTT1 null genotypes in modulating radiation-induced aberrations. These findings underscore the role of genetic susceptibility, particularly involving GSTM1 and GSTT1 CNVs, in modulating radiation-induced chromosomal damage. The observed gene&#x02013;environment interaction in the relatively high-exposure group suggests that pre-existing CNVs contribute to chromosomal instability under radiation exposure.</p></abstract><kwd-group><kwd>ionizing radiation</kwd><kwd>chromosome aberration</kwd><kwd>copy number variation</kwd><kwd>glutathione S-transferase mu-1 (GSTM1)</kwd><kwd>glutathione S-transferase theta-1 (GSTT1)</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-toxics-13-00073"><title>1. Introduction</title><p>Ionizing radiation (IR) is widely utilized across diverse industries, notably in healthcare, research, and nuclear power generation. As reliance on IR continues to grow, the risks associated with occupational exposure, even at low doses, demand increasing attention. Despite strict regulations by organizations such as the International Commission on Radiological Protection (ICRP), prolonged low-dose IR exposure poses significant health concerns, particularly in terms of its genotoxic effects [<xref rid="B1-toxics-13-00073" ref-type="bibr">1</xref>,<xref rid="B2-toxics-13-00073" ref-type="bibr">2</xref>]. Radiation-induced chromosomal aberrations (CAs) are well-studied markers of genomic instability and are critical in understanding the biological effects of radiation. These aberrations reflect cumulative damage over time and contribute to long-term health complications [<xref rid="B3-toxics-13-00073" ref-type="bibr">3</xref>].</p><p>In occupational health research, identifying biomarkers for individual radiosensitivity has become crucial for risk assessment and worker protection strategies [<xref rid="B4-toxics-13-00073" ref-type="bibr">4</xref>]. Chromosomal aberrations detected in peripheral blood lymphocytes (PBLs) have been extensively utilized as biomarkers to assess genotoxic effects caused by ionizing radiation [<xref rid="B5-toxics-13-00073" ref-type="bibr">5</xref>,<xref rid="B6-toxics-13-00073" ref-type="bibr">6</xref>] and to explore the potential role of high CA frequencies as an early marker of cancer risk [<xref rid="B7-toxics-13-00073" ref-type="bibr">7</xref>,<xref rid="B8-toxics-13-00073" ref-type="bibr">8</xref>,<xref rid="B9-toxics-13-00073" ref-type="bibr">9</xref>].</p><p>IR primarily causes damage through two mechanisms: direct DNA ionization and the generation of reactive oxygen species (ROS), both of which lead to significant DNA damage [<xref rid="B10-toxics-13-00073" ref-type="bibr">10</xref>,<xref rid="B11-toxics-13-00073" ref-type="bibr">11</xref>]. ROS-driven oxidative stress exacerbates DNA damage and promotes mutations, increasing cancer risk [<xref rid="B12-toxics-13-00073" ref-type="bibr">12</xref>]. In this context, the glutathione S-transferase (GST) enzyme family plays a critical role in neutralizing ROS and detoxifying harmful metabolites [<xref rid="B13-toxics-13-00073" ref-type="bibr">13</xref>]. Among these enzymes, GSTM1 and GSTT1 are particularly notable for mitigating oxidative damage. Polymorphisms in the genes encoding these enzymes, particularly deletion variants, reduce or eliminate enzyme activity, increasing susceptibility to genotoxic effects. These genetic deletions have also been associated with a heightened risk of cancer and other diseases, highlighting their potential as biomarkers for IR-induced damage [<xref rid="B14-toxics-13-00073" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00073" ref-type="bibr">15</xref>].</p><p>While numerous studies have explored the role of GST polymorphisms in cancer and other oxidative stress-related conditions, the association between GSTM1 and GSTT1 deletions and susceptibility to IR-induced chromosomal aberrations in occupational settings remains underexplored. Previous studies often faced limitations such as small sample sizes or oversimplified genotyping approaches, which may have underestimated the true associations between GSTM1 and GSTT1 copy numbers and IR-induced DNA damage [<xref rid="B16-toxics-13-00073" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00073" ref-type="bibr">17</xref>]. More precise determination of gene copy numbers now allows for a detailed investigation of their potential contribution to radiosensitivity in exposed populations [<xref rid="B18-toxics-13-00073" ref-type="bibr">18</xref>].</p><p>The primary aim of this study is to assess the association between GSTM1 and GSTT1 copy number variations and the frequency of chromosomal aberrations in nuclear power plant workers exposed to low-dose IR. By examining these genetic factors in relation to chromosomal aberration data, this research seeks to provide insights into the role of GST polymorphisms in modulating the genotoxic effects of radiation exposure.</p></sec><sec id="sec2-toxics-13-00073"><title>2. Materials and Methods</title><sec id="sec2dot1-toxics-13-00073"><title>2.1. Ethics Statement</title><p>The study protocol was approved by the Research Ethics Review Board of Seoul National University. All participants provided written informed consent before inclusion in the study.</p></sec><sec id="sec2dot2-toxics-13-00073"><title>2.2. Study Population</title><p>This study builds on previous research investigating chromosomal damage in nuclear power plant workers exposed to low-dose ionizing radiation [<xref rid="B19-toxics-13-00073" ref-type="bibr">19</xref>]. The study included 108 male workers occupationally exposed to low doses of ionizing radiation (IR) at four nuclear power plants in South Korea (Kori, Wolsong, Yonggwang, and Ulchin). The control group consisted of 45 male office workers employed at the same nuclear power plants. These individuals were not occupationally exposed to radiation, as their job roles did not involve direct contact with radiation sources. Blood samples from both groups were collected during the same period. Occupational radiation doses were determined using official personal dosimetry records obtained from the Korean National Dose Registry, managed by the Korea Radio-Isotope Association (KRIA).</p></sec><sec id="sec2dot3-toxics-13-00073"><title>2.3. DNA Isolation and Copy Number Assays</title><p>Genomic DNA was isolated from 2 mL of peripheral whole blood using the Wizard&#x02122; DNA Purification Kit (Promega, Madison, WI, USA). The protocol involved cell lysis, protein precipitation, and DNA precipitation with isopropanol. After ethanol washing, the DNA was resuspended in TE buffer and stored at &#x02212;20 &#x000b0;C until analysis. DNA concentration and purity were checked using a NanoDrop spectrophotometer, ensuring OD 260/280 ratios between 1.8 and 2.0. The copy numbers of GSTM1 and GSTT1 were determined using quantitative real-time PCR (qPCR) with TaqMan<sup>&#x000ae;</sup> Copy Number Assays (Applied Biosystems, USA). The Hs02575461_cn assay was used for GSTM1, and Hs00010004_cn for GSTT1, with the RNase P gene as a reference to normalize copy number estimates. Each qPCR reaction (20 &#x003bc;L) contained TaqMan<sup>&#x000ae;</sup> Universal PCR Master Mix, the respective TaqMan Copy Number Assay, and a DNA sample diluted to 5 ng/&#x003bc;L. The qPCR reactions were run in triplicate on a 7300 Real-Time PCR System. The cycling conditions included an initial denaturation at 95 &#x000b0;C for 10 min, followed by 40 cycles of 95 &#x000b0;C for 15 s and 60 &#x000b0;C for 1 min.</p><p>The comparative &#x00394;&#x00394;Ct method was applied to calculate the relative copy number. Ct values from GSTM1 and GSTT1 were normalized to those of the reference gene (RNase P) in each sample. A calibrator sample with known two-copy status was used for accuracy, and the relative quantity (2^&#x00394;&#x00394;Ct) was multiplied by two to estimate copy numbers in the diploid genome. No-template controls were included in each plate to control for contamination. For quality control, any samples with standard deviations greater than 0.5 in Ct values among triplicates were flagged for re-analysis. Random samples were also repeated, yielding 100% concordance with the initial results.</p></sec><sec id="sec2dot4-toxics-13-00073"><title>2.4. Chromosome Aberration (CA) Assay</title><p>Peripheral blood samples were collected from each participant in heparinized tubes. Samples were processed immediately, and 1 mL of blood was seeded in 9 mL of RPMI 1640 culture medium supplemented with fetal bovine serum (10%), antibiotics, and phytohemagglutinin to stimulate lymphocyte growth. The cultures were incubated at 37 &#x000b0;C in a humidified atmosphere containing 5% CO<sub>2</sub> for 48 h. Colcemid (0.1 &#x003bc;g/mL) was added 3 h before harvesting to arrest cells in metaphase. Chromosome preparations were performed according to the standard procedure [<xref rid="B20-toxics-13-00073" ref-type="bibr">20</xref>]. Slides were coded blindly, and 500 metaphases for each subject were scored randomly. The aberration types, including chromatid type and chromosome type, were counted separately.</p><p>Fluorescence plus Giemsa (FPG) staining for sister chromatids [<xref rid="B21-toxics-13-00073" ref-type="bibr">21</xref>] was performed to differentiate between first and second cell divisions. Chromosomal aberrations were analyzed exclusively in cells from the first division, confirmed by BrdU incorporation, which showed that 87&#x02013;95% (average 90.5%) of observed cells were in the first division.</p></sec><sec id="sec2dot5-toxics-13-00073"><title>2.5. Statistical Analysis</title><p>Data were analyzed using SAS 9.1 software (SAS Institute Inc., Cary, NC, USA). Differences in the frequency of chromosome aberrations between nuclear power plant workers and controls were analyzed by the Mann&#x02013;Whitney U-test. Kruskal&#x02013;Wallis Tests and Mann&#x02013;Whitney U-tests were employed to compare GST copy numbers and chromosomal aberrations, as well as to examine GST copy number distributions between radiation-exposed workers and controls. Poisson regression models were subsequently used to estimate frequency ratios (FRs) of aberrations, adjusting for age, smoking, alcohol consumption, and radiation dose, with differences considered statistically significant at <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec3-toxics-13-00073"><title>3. Results</title><sec id="sec3dot1-toxics-13-00073"><title>3.1. General Characteristics of Study Population</title><p>The general characteristics of the study population are summarized in <xref rid="toxics-13-00073-t001" ref-type="table">Table 1</xref>. A total of 180 radiation-exposed workers and 45 control subjects were included in the study. The mean age of the radiation-exposed workers was 47.5 &#x000b1; 5.9 years, while the control subjects had a mean age of 40.9 &#x000b1; 10.0 years. There were no significant differences in smoking status between the two groups. However, a significant difference was found in alcohol consumption, with 81.7% of radiation-exposed workers reporting alcohol use compared to 66.7% of the controls (<italic toggle="yes">p</italic> = 0.01). The cumulative radiation dose for the exposed workers ranged from 12.7 to 400.3 mSv, with a mean of 157.3 &#x000b1; 85.2 mSv.</p></sec><sec id="sec3dot2-toxics-13-00073"><title>3.2. Chromosomal Aberration Frequency</title><p>Radiation-exposed workers exhibited significantly higher chromosomal aberration (CA) frequencies compared to controls (<xref rid="toxics-13-00073-t002" ref-type="table">Table 2</xref>). The mean frequency of chromatid-type aberrations was 5.47 per 500 metaphase cells in the exposed workers, significantly higher than 3.57 in the controls (<italic toggle="yes">p</italic> &#x0003c; 0.001). Similarly, the mean frequency of chromosome-type aberrations was 3.01 per 500 cells in the exposed workers, compared to 0.64 in the controls (<italic toggle="yes">p</italic> &#x0003c; 0.001). These significant differences remained even after adjusting for confounding factors such as age, smoking status, and alcohol consumption using Poisson regression analysis.</p></sec><sec id="sec3dot3-toxics-13-00073"><title>3.3. GSTM1 and GSTT1 Copy Number Distributions</title><p>The distributions of GSTM1 and GSTT1 copy numbers in radiation-exposed workers and controls are shown in <xref rid="toxics-13-00073-t003" ref-type="table">Table 3</xref>. There were no statistically significant differences between the two groups in terms of the copy number distribution for both genes. In the study population, the frequency of GSTM1 null genotypes (zero copies) was 50.67%, and for GSTT1, it was 49.78%, which is similar to previously reported values for East Asian populations (GSTM1 null: 52%, GSTT1 null: 48%) [<xref rid="B22-toxics-13-00073" ref-type="bibr">22</xref>]. The frequencies of individuals with two copies of GSTM1 and GSTT1 were 8.89% and 9.78%, respectively.</p></sec><sec id="sec3dot4-toxics-13-00073"><title>3.4. Association Between GST Copy Number and Chromosomal Aberrations</title><p>As shown in <xref rid="toxics-13-00073-t004" ref-type="table">Table 4</xref>, no significant correlation was found between GSTM1 and GSTT1 copy numbers and chromosomal aberration frequencies across groups with zero, one, or two or more copies. Individuals with two copies of GSTM1 or GSTT1 only exhibited a slightly lower mean frequency of chromosome aberrations compared to those with zero copies or one copy, but there was no statistical significance.</p><p>For further analyses, exposed workers were categorized into two groups based on their recent 1.5-year radiation exposure levels: the relatively low-exposure group (&#x02264;7.5 mSv, <italic toggle="yes">n</italic> = 89) and the relatively high-exposure group (&#x02265;7.5 mSv, <italic toggle="yes">n</italic> = 91).</p><p><xref rid="toxics-13-00073-f001" ref-type="fig">Figure 1</xref> illustrates the relationships between GSTM1 and GSTT1 copy numbers and chromosomal aberration frequencies across different radiation exposure levels. In the high-exposure group, higher copy numbers of GSTM1 and GSTT1 were associated with lower frequencies of chromatid-type aberrations. For GSTM1, individuals in the relatively high-exposure group with zero copies exhibited a higher frequency, of 6.37 &#x000b1; 3.47 per 500 cells, compared to 5.02 &#x000b1; 3.05 for one copy and 4.67 &#x000b1; 2.40 for two copies (<italic toggle="yes">p</italic> = 0.06). Similarly, for GSTT1, frequencies in the relatively high-exposure group decreased from 6.00 &#x000b1; 3.29 for zero copies to 5.38 &#x000b1; 2.79 and 4.11 &#x000b1; 4.26 for one and two copies, respectively (<italic toggle="yes">p</italic> = 0.05).</p><p>Multivariate analysis further confirmed an inverse relationship between GSTM1 and GSTT1 copy numbers and the frequency of chromatid-type aberrations in the high-exposure group, even after adjusting for confounders such as smoking, age, alcohol intake, and recent radiation exposure dose (<xref rid="toxics-13-00073-t005" ref-type="table">Table 5</xref>). For GSTM1, individuals with one or more copies exhibited lower chromatid-type aberration frequencies compared to those with zero copies (e.g., FR = 0.77, 95% CI = 0.64&#x02013;0.93 for one copy; FR = 0.71, 95% CI = 0.51&#x02013;0.98 for two or more copies). A similar trend was observed for GSTT1, where frequencies decreased progressively from zero copies (reference) to one copy (FR = 0.93, 95% CI = 0.77&#x02013;1.13) and two or more copies (FR = 0.70, 95% CI = 0.49&#x02013;0.99).</p><p>As shown in <xref rid="toxics-13-00073-f002" ref-type="fig">Figure 2</xref>, individuals carrying double-null genotypes had a 1.36-fold increase (95% CI: 1.03&#x02013;1.81) in chromatid-type aberrations compared to those with the highest copy number (reference group) in the high-exposure group. This highlights the combination of GSTM1 and GSTT1 copy numbers&#x02019; interaction with radiation exposure levels.</p></sec></sec><sec sec-type="discussion" id="sec4-toxics-13-00073"><title>4. Discussion</title><p>This study highlights the role of GSTM1 and GSTT1 copy number variations in influencing susceptibility to radiation-induced chromosomal aberrations (CAs) among nuclear power plant workers.</p><p>The CA frequency was significantly higher in radiation-exposed workers compared to controls, consistent with earlier findings [<xref rid="B6-toxics-13-00073" ref-type="bibr">6</xref>,<xref rid="B23-toxics-13-00073" ref-type="bibr">23</xref>,<xref rid="B24-toxics-13-00073" ref-type="bibr">24</xref>]. Chromatid-type aberrations were particularly dominant in our study, as also demonstrated by Shatha [<xref rid="B25-toxics-13-00073" ref-type="bibr">25</xref>], which highlighted the prominence of chromatid-type damage in in vitro low-dose conditions. This difference may be attributed to radiation-induced reactive oxygen species (ROS), which drive genomic instability and DNA damage. At lower radiation doses, ROS play a critical role in promoting chromatid-type aberrations, likely through the induction of oxidative stress and subsequent genomic instability [<xref rid="B26-toxics-13-00073" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00073" ref-type="bibr">27</xref>]. Under prolonged oxidative stress, ROS-induced SSBs may persist and convert into DSBs during replication, contributing to genomic instability [<xref rid="B27-toxics-13-00073" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00073" ref-type="bibr">28</xref>]. As described by Kryston et al. [<xref rid="B29-toxics-13-00073" ref-type="bibr">29</xref>], oxidative DNA damage can lead to clustered lesions, which are challenging to repair and may be associated with chromatid-type aberrations.</p><p>GST copy number variations did not show a significant correlation with chromosomal aberrations in our study (<xref rid="toxics-13-00073-t004" ref-type="table">Table 4</xref>). A similar lack of association was reported by Gulati et al. [<xref rid="B17-toxics-13-00073" ref-type="bibr">17</xref>], who found no direct link between GST polymorphisms and DNA damage in individuals exposed to mobile tower radiation. When we considered radiation exposure levels, an inverse association between GSTM1 and GSTT1 copy numbers and chromosomal aberrations became evident, particularly in occupational settings with relatively high radiation exposure. Individuals with null genotypes showed higher chromosomal damage, suggesting that genetic predisposition plays a crucial role in determining radiosensitivity under heightened environmental stress [<xref rid="B10-toxics-13-00073" ref-type="bibr">10</xref>,<xref rid="B11-toxics-13-00073" ref-type="bibr">11</xref>,<xref rid="B30-toxics-13-00073" ref-type="bibr">30</xref>]. Furthermore, individuals with double-null genotypes exhibited the highest chromosomal aberration frequencies, indicating a combined effect of GSTM1 and GSTT1 deficiencies in amplifying radiation-induced oxidative stress. This combination highlights a synergy effect in modulating radiation-induced aberrations, consistent with previous studies reporting increased chromosomal damage in radiation workers and individuals exposed to various genotoxic agents [<xref rid="B31-toxics-13-00073" ref-type="bibr">31</xref>,<xref rid="B32-toxics-13-00073" ref-type="bibr">32</xref>]. This combined effect suggests a gene&#x02013;environment interaction, where genetic susceptibility becomes more pronounced under environmental stressors such as radiation exposure, as predicted by Ottman&#x02019;s model [<xref rid="B33-toxics-13-00073" ref-type="bibr">33</xref>]. The synergistic effect of GSTM1 and GSTT1 null genotypes on chromosomal aberrations highlights the necessity of incorporating gene&#x02013;environment interactions into occupational radiation risk assessments.</p><p>The role of GSTM1 and GSTT1 enzymes in detoxifying ROS provides a possible explanation for these observations. When these enzymes are absent due to null genotypes, ROS can accumulate, increasing oxidative stress and resulting in chromatid-type aberrations [<xref rid="B7-toxics-13-00073" ref-type="bibr">7</xref>,<xref rid="B25-toxics-13-00073" ref-type="bibr">25</xref>,<xref rid="B34-toxics-13-00073" ref-type="bibr">34</xref>]. This gene dosage effect, where increased copy numbers enhance enzymatic activity, was evident in our findings. Given that oxidative stress plays a key role in radiation-induced genomic instability, previous studies have also reported that GSTM1 and GSTT1 null genotypes are linked to heightened oxidative stress in radiation-exposed workers [<xref rid="B35-toxics-13-00073" ref-type="bibr">35</xref>], further reinforcing their role in modulating radiosensitivity. Individuals with one or more copies of GSTM1 and GSTT1 showed lower chromosomal aberration frequencies compared to those with null genotypes, demonstrating the protective role of these enzymes against oxidative stress [<xref rid="B30-toxics-13-00073" ref-type="bibr">30</xref>,<xref rid="B36-toxics-13-00073" ref-type="bibr">36</xref>]. Similarly, Glushkov et al. [<xref rid="B31-toxics-13-00073" ref-type="bibr">31</xref>] demonstrated that GSTM1 and GSTT1 null genotypes enhance chromosomal damage under environmental stressors, such as smoking and occupational chemical exposure. In addition, Zeng et al. [<xref rid="B37-toxics-13-00073" ref-type="bibr">37</xref>] showed that GSTM1 null and GSTT1 null genotypes increase susceptibility to respiratory inflammation caused by particulate matter in air pollution. Together, these findings underscore the role of GST polymorphisms in modulating the biological impact of environmental stressors.</p><p>Genetic analyses in occupational settings can provide valuable insights into individual susceptibility, complementing physical dosimetry by integrating biological markers such as chromosomal aberrations to improve radiation exposure assessment. However, further research with larger sample sizes and the inclusion of diverse genetic factors is essential to validate these findings and better understand their role in modulating genomic instability under varying levels of radiation exposure.</p></sec><sec sec-type="conclusions" id="sec5-toxics-13-00073"><title>5. Conclusions</title><p>This study highlights the significant role of GSTM1 and GSTT1 copy number variations in determining susceptibility to chromosomal aberrations in nuclear power plant workers exposed to low-dose ionizing radiation. Null genotypes for these genes were associated with higher frequencies of chromatid-type aberrations, indicating increased vulnerability to radiation-induced damage.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>J.w.L. designed and conducted the study, analyzed the data, and wrote the initial draft of the article. J.w.L. and Y.L. performed the experiments. Y.J.K. contributed to the study design, provided critical revisions, and approved the final version of the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study protocol was approved by the Research Ethics Review Board of Seoul National University (protocol no. 0805 of 20 July 2009).</p></notes><notes><title>Informed Consent Statement</title><p>Written informed consent was obtained from participating subjects.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest related to the research, authorship, or publication of this article.</p></notes><ref-list><title>References</title><ref id="B1-toxics-13-00073"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mullenders</surname><given-names>L.</given-names></name>
<name><surname>Atkinson</surname><given-names>M.</given-names></name>
<name><surname>Paretzke</surname><given-names>H.</given-names></name>
<name><surname>Sabatier</surname><given-names>L.</given-names></name>
<name><surname>Bouffler</surname><given-names>S.</given-names></name>
</person-group><article-title>Assessing cancer risks of low-dose radiation</article-title><source>Nat. Rev. Cancer</source><year>2009</year><volume>9</volume><fpage>U596</fpage><lpage>U604</lpage><pub-id pub-id-type="doi">10.1038/nrc2677</pub-id><pub-id pub-id-type="pmid">19629073</pub-id>
</element-citation></ref><ref id="B2-toxics-13-00073"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eken</surname><given-names>A.</given-names></name>
<name><surname>Aydin</surname><given-names>A.</given-names></name>
<name><surname>Erdem</surname><given-names>O.</given-names></name>
<name><surname>Akay</surname><given-names>C.</given-names></name>
<name><surname>Sanal</surname><given-names>H.T.</given-names></name>
<name><surname>Soykut</surname><given-names>B.</given-names></name>
<name><surname>Sayal</surname><given-names>A.</given-names></name>
<name><surname>Somuncu</surname><given-names>I.</given-names></name>
</person-group><article-title>Cytogenetic analysis of peripheral blood lymphocytes of hospital staff occupationally exposed to low doses of ionizing radiation</article-title><source>Toxicol. Ind. Health</source><year>2010</year><volume>26</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1177/0748233710365693</pub-id><pub-id pub-id-type="pmid">20371634</pub-id>
</element-citation></ref><ref id="B3-toxics-13-00073"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Snyder</surname><given-names>A.R.</given-names></name>
<name><surname>Morgan</surname><given-names>W.F.</given-names></name>
</person-group><article-title>Radiation-induced genomic instability and its implications for radiation carcinogenesis</article-title><source>Oncogene</source><year>2003</year><volume>22</volume><fpage>5848</fpage><lpage>5854</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1206697</pub-id><pub-id pub-id-type="pmid">12947391</pub-id>
</element-citation></ref><ref id="B4-toxics-13-00073"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Straume</surname><given-names>T.</given-names></name>
<name><surname>Amundson</surname><given-names>S.A.</given-names></name>
<name><surname>Blakely</surname><given-names>W.F.</given-names></name>
<name><surname>Burns</surname><given-names>F.J.</given-names></name>
<name><surname>Chen</surname><given-names>A.</given-names></name>
<name><surname>Dainiak</surname><given-names>N.</given-names></name>
<name><surname>Franklin</surname><given-names>S.</given-names></name>
<name><surname>Leary</surname><given-names>J.A.</given-names></name>
<name><surname>Loftus</surname><given-names>D.J.</given-names></name>
<name><surname>Morgan</surname><given-names>W.F.</given-names></name>
</person-group><article-title>NASA Radiation Biomarker Workshop September 27&#x02013;28, 2007</article-title><source>Radiat. Res.</source><year>2008</year><volume>170</volume><fpage>393</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1667/RR1382.1</pub-id><pub-id pub-id-type="pmid">18763867</pub-id>
</element-citation></ref><ref id="B5-toxics-13-00073"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saberi</surname><given-names>A.</given-names></name>
<name><surname>Salari</surname><given-names>E.</given-names></name>
<name><surname>Latifi</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Cytogenetic analysis in lymphocytes from radiation workers exposed to low level of ionizing radiation in radiotherapy, CT-scan and angiocardiography units</article-title><source>Mutat. Res.</source><year>2013</year><volume>750</volume><fpage>92</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2012.10.001</pub-id><pub-id pub-id-type="pmid">23073478</pub-id>
</element-citation></ref><ref id="B6-toxics-13-00073"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Djokovic</surname><given-names>J.</given-names></name>
<name><surname>Jankovic</surname><given-names>S.</given-names></name>
<name><surname>Milovanovic</surname><given-names>A.</given-names></name>
<name><surname>Bulat</surname><given-names>P.</given-names></name>
</person-group><article-title>Chromosomal Aberrations, Micronuclei, Blood Parameters and Received Doses in Workers Exposed to Ionizing Radiation</article-title><source>Med Lav.</source><year>2023</year><volume>114</volume><fpage>e2023036</fpage><pub-id pub-id-type="pmid">37534426</pub-id>
</element-citation></ref><ref id="B7-toxics-13-00073"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonassi</surname><given-names>S.</given-names></name>
<name><surname>Norppa</surname><given-names>H.</given-names></name>
<name><surname>Ceppi</surname><given-names>M.</given-names></name>
<name><surname>Str&#x000f6;mberg</surname><given-names>U.</given-names></name>
<name><surname>Vermeulen</surname><given-names>R.</given-names></name>
<name><surname>Znaor</surname><given-names>A.</given-names></name>
<name><surname>Cebulska-Wasilewska</surname><given-names>A.</given-names></name>
<name><surname>Fabianova</surname><given-names>E.</given-names></name>
<name><surname>Fucic</surname><given-names>A.</given-names></name>
<name><surname>Gundy</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: Results from a pooled cohort study of 22,358 subjects in 11 countries</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>1178</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgn075</pub-id><pub-id pub-id-type="pmid">18356148</pub-id>
</element-citation></ref><ref id="B8-toxics-13-00073"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boffetta</surname><given-names>P.</given-names></name>
<name><surname>van der Hel</surname><given-names>O.</given-names></name>
<name><surname>Norppa</surname><given-names>H.</given-names></name>
<name><surname>Fabianova</surname><given-names>E.</given-names></name>
<name><surname>Fucic</surname><given-names>A.</given-names></name>
<name><surname>Gundy</surname><given-names>S.</given-names></name>
<name><surname>Lazutka</surname><given-names>J.</given-names></name>
<name><surname>Cebulska-Wasilewska</surname><given-names>A.</given-names></name>
<name><surname>Puskailerova</surname><given-names>D.</given-names></name>
<name><surname>Znaor</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Chromosomal aberrations and cancer risk: Results of a cohort study from Central Europe</article-title><source>Am. J. Epidemiol.</source><year>2007</year><volume>165</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1093/aje/kwj367</pub-id><pub-id pub-id-type="pmid">17071846</pub-id>
</element-citation></ref><ref id="B9-toxics-13-00073"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vodenkova</surname><given-names>S.</given-names></name>
<name><surname>Polivkova</surname><given-names>Z.</given-names></name>
<name><surname>Musak</surname><given-names>L.</given-names></name>
<name><surname>Smerhovsky</surname><given-names>Z.</given-names></name>
<name><surname>Zoubkova</surname><given-names>H.</given-names></name>
<name><surname>Sytarova</surname><given-names>S.</given-names></name>
<name><surname>Kavcova</surname><given-names>E.</given-names></name>
<name><surname>Halasova</surname><given-names>E.</given-names></name>
<name><surname>Vodickova</surname><given-names>L.</given-names></name>
<name><surname>Jiraskova</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Structural chromosomal aberrations as potential risk markers in incident cancer patients</article-title><source>Mutagenesis</source><year>2015</year><volume>30</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1093/mutage/gev018</pub-id><pub-id pub-id-type="pmid">25800034</pub-id>
</element-citation></ref><ref id="B10-toxics-13-00073"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Little</surname><given-names>J.B.</given-names></name>
</person-group><article-title>Radiation-induced genomic instability</article-title><source>Int. J. Radiat. Biol.</source><year>1998</year><volume>74</volume><fpage>663</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1080/095530098140925</pub-id><pub-id pub-id-type="pmid">9881710</pub-id>
</element-citation></ref><ref id="B11-toxics-13-00073"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Trachootham</surname><given-names>D.</given-names></name>
<name><surname>Alexandre</surname><given-names>J.</given-names></name>
<name><surname>Huang</surname><given-names>P.</given-names></name>
</person-group><article-title>Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?</article-title><source>Nat. Rev. Drug Discov.</source><year>2009</year><volume>8</volume><fpage>579</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/nrd2803</pub-id><pub-id pub-id-type="pmid">19478820</pub-id>
</element-citation></ref><ref id="B12-toxics-13-00073"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tiwari</surname><given-names>P.</given-names></name>
<name><surname>Kumar</surname><given-names>A.</given-names></name>
<name><surname>Balakrishnan</surname><given-names>S.</given-names></name>
<name><surname>Kushwaha</surname><given-names>H.S.</given-names></name>
<name><surname>Mishra</surname><given-names>K.P.</given-names></name>
</person-group><article-title>Radiation-induced micronucleus formation and DNA damage in human lymphocytes and their prevention by antioxidant thiols</article-title><source>Mutat. Res.</source><year>2009</year><volume>676</volume><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2009.03.007</pub-id><pub-id pub-id-type="pmid">19486866</pub-id>
</element-citation></ref><ref id="B13-toxics-13-00073"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayes</surname><given-names>J.D.</given-names></name>
<name><surname>Flanagan</surname><given-names>J.U.</given-names></name>
<name><surname>Jowsey</surname><given-names>I.R.</given-names></name>
</person-group><article-title>Glutathione transferases</article-title><source>Annu. Rev. Pharmacol. Toxicol.</source><year>2005</year><volume>45</volume><fpage>51</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.45.120403.095857</pub-id><pub-id pub-id-type="pmid">15822171</pub-id>
</element-citation></ref><ref id="B14-toxics-13-00073"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alexandrie</surname><given-names>A.K.</given-names></name>
<name><surname>Nyberg</surname><given-names>F.</given-names></name>
<name><surname>Warholm</surname><given-names>M.</given-names></name>
<name><surname>Rannug</surname><given-names>A.</given-names></name>
</person-group><article-title>Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population</article-title><source>Cancer Epidemiol. Biomarkers Prev.</source><year>2004</year><volume>13</volume><fpage>908</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.908.13.6</pub-id><pub-id pub-id-type="pmid">15184245</pub-id>
</element-citation></ref><ref id="B15-toxics-13-00073"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rajagopal</surname><given-names>R.</given-names></name>
<name><surname>Deakin</surname><given-names>M.</given-names></name>
<name><surname>Fawole</surname><given-names>A.</given-names></name>
<name><surname>Elder</surname><given-names>J.</given-names></name>
<name><surname>Smith</surname><given-names>V.</given-names></name>
<name><surname>Strange</surname><given-names>R.</given-names></name>
<name><surname>Fryer</surname><given-names>A.</given-names></name>
</person-group><article-title>Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer</article-title><source>Carcinogenesis</source><year>2005</year><volume>26</volume><fpage>2157</fpage><pub-id pub-id-type="doi">10.1093/carcin/bgi195</pub-id><pub-id pub-id-type="pmid">16051638</pub-id>
</element-citation></ref><ref id="B16-toxics-13-00073"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mangoni</surname><given-names>M.</given-names></name>
<name><surname>Bisanzi</surname><given-names>S.</given-names></name>
<name><surname>Carozzi</surname><given-names>F.</given-names></name>
<name><surname>Sani</surname><given-names>C.</given-names></name>
<name><surname>Biti</surname><given-names>G.</given-names></name>
<name><surname>Livi</surname><given-names>L.</given-names></name>
<name><surname>Barletta</surname><given-names>E.</given-names></name>
<name><surname>Costantini</surname><given-names>A.S.</given-names></name>
<name><surname>Gorini</surname><given-names>G.</given-names></name>
</person-group><article-title>Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients</article-title><source>Int. J. Radiat. Oncol. Biol. Phys.</source><year>2011</year><volume>81</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2010.04.023</pub-id><pub-id pub-id-type="pmid">20708344</pub-id>
</element-citation></ref><ref id="B17-toxics-13-00073"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gulati</surname><given-names>S.</given-names></name>
<name><surname>Yadav</surname><given-names>A.</given-names></name>
<name><surname>Kumar</surname><given-names>N.</given-names></name>
<name><surname>Kanupriya</surname></name>
<name><surname>Aggarwal</surname><given-names>N.K.</given-names></name>
<name><surname>Kumar</surname><given-names>R.</given-names></name>
<name><surname>Gupta</surname><given-names>R.</given-names></name>
</person-group><article-title>Effect of GSTM1 and GSTT1 Polymorphisms on Genetic Damage in Humans Populations Exposed to Radiation From Mobile Towers</article-title><source>Arch. Environ. Contam. Toxicol.</source><year>2016</year><volume>70</volume><fpage>615</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1007/s00244-015-0195-y</pub-id><pub-id pub-id-type="pmid">26238667</pub-id>
</element-citation></ref><ref id="B18-toxics-13-00073"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoebeeck</surname><given-names>J.</given-names></name>
<name><surname>Speleman</surname><given-names>F.</given-names></name>
<name><surname>Vandesompele</surname><given-names>J.</given-names></name>
</person-group><article-title>Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes</article-title><source>Methods Mol. Biol.</source><year>2007</year><volume>353</volume><fpage>205</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">17332643</pub-id>
</element-citation></ref><ref id="B19-toxics-13-00073"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>Y.J.</given-names></name>
<name><surname>Lee</surname><given-names>J.W.</given-names></name>
<name><surname>Cho</surname><given-names>Y.H.</given-names></name>
<name><surname>Choi</surname><given-names>Y.J.</given-names></name>
<name><surname>Lee</surname><given-names>Y.</given-names></name>
<name><surname>Chung</surname><given-names>H.W.</given-names></name>
</person-group><article-title>Chromosome damage in relation to recent radiation exposure and radiation quality in nuclear power plant workers</article-title><source>Toxics</source><year>2022</year><volume>10</volume><elocation-id>94</elocation-id><pub-id pub-id-type="doi">10.3390/toxics10020094</pub-id><pub-id pub-id-type="pmid">35202280</pub-id>
</element-citation></ref><ref id="B20-toxics-13-00073"><label>20.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>IAEA</collab>
</person-group><source>Cytogenetic Analysis for Radiation Dose Assessment: A Manual</source><series>Technical Report Series No. 405</series><publisher-name>IAEA</publisher-name><publisher-loc>Vienna, Austria</publisher-loc><year>2001</year></element-citation></ref><ref id="B21-toxics-13-00073"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perry</surname><given-names>P.</given-names></name>
<name><surname>Wolff</surname><given-names>S.</given-names></name>
</person-group><article-title>New Giemsa method for the differential staining of sister chromatids</article-title><source>Nature</source><year>1974</year><volume>251</volume><fpage>156</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1038/251156a0</pub-id><pub-id pub-id-type="pmid">4138930</pub-id>
</element-citation></ref><ref id="B22-toxics-13-00073"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakanishi</surname><given-names>G.</given-names></name>
<name><surname>Pita-Oliveira</surname><given-names>M.</given-names></name>
<name><surname>Bertagnolli</surname><given-names>L.S.</given-names></name>
<name><surname>Torres-Loureiro</surname><given-names>S.</given-names></name>
<name><surname>Scudeler</surname><given-names>M.M.</given-names></name>
<name><surname>Cirino</surname><given-names>H.S.</given-names></name>
<name><surname>Chaves</surname><given-names>M.L.</given-names></name>
<name><surname>Miwa</surname><given-names>B.</given-names></name>
<name><surname>Rodrigues-Soares</surname><given-names>F.</given-names></name>
</person-group><article-title>Worldwide systematic review of GSTM1 and GSTT1 null genotypes by continent, ethnicity, and therapeutic area</article-title><source>OMICS</source><year>2022</year><volume>26</volume><fpage>528</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1089/omi.2022.0090</pub-id><pub-id pub-id-type="pmid">36112350</pub-id>
</element-citation></ref><ref id="B23-toxics-13-00073"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zakeri</surname><given-names>F.</given-names></name>
<name><surname>Hirobe</surname><given-names>T.</given-names></name>
</person-group><article-title>A cytogenetic approach to the effects of low levels of ionizing radiations on occupationally exposed individuals</article-title><source>Eur. J. Radiol.</source><year>2010</year><volume>73</volume><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.ejrad.2008.10.015</pub-id><pub-id pub-id-type="pmid">19054641</pub-id>
</element-citation></ref><ref id="B24-toxics-13-00073"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>H.W.</given-names></name>
<name><surname>Ryu</surname><given-names>E.K.</given-names></name>
<name><surname>Kim</surname><given-names>Y.J.</given-names></name>
<name><surname>Ha</surname><given-names>S.W.</given-names></name>
</person-group><article-title>Chromosome aberrations in workers of nuclear-power plants</article-title><source>Mutat. Res.</source><year>1996</year><volume>350</volume><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/0027-5107(95)00118-2</pub-id><pub-id pub-id-type="pmid">8600360</pub-id>
</element-citation></ref><ref id="B25-toxics-13-00073"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shatha</surname><given-names>F.</given-names></name>
</person-group><article-title>Quantifying the Biological Effects of Medical Radiation Exposure on Human Cells, Lymphocyte as a Model</article-title><source>Int. J. Med. Eval. Phys. Rep.</source><year>2024</year><volume>8</volume><fpage>63</fpage><lpage>75</lpage></element-citation></ref><ref id="B26-toxics-13-00073"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kawamura</surname><given-names>K.</given-names></name>
<name><surname>Qi</surname><given-names>F.</given-names></name>
<name><surname>Kobayashi</surname><given-names>J.</given-names></name>
</person-group><article-title>Potential relationship between the biological effects of low-dose IR and mitochondrial ROS production</article-title><source>J. Radiat. Res.</source><year>2018</year><volume>59</volume><fpage>ii91</fpage><lpage>ii97</lpage><pub-id pub-id-type="doi">10.1093/jrr/rrx091</pub-id><pub-id pub-id-type="pmid">29415254</pub-id>
</element-citation></ref><ref id="B27-toxics-13-00073"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Azzam</surname><given-names>E.I.</given-names></name>
<name><surname>Jay-Gerin</surname><given-names>J.P.</given-names></name>
<name><surname>Pain</surname><given-names>D.</given-names></name>
</person-group><article-title>Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury</article-title><source>Cancer Lett.</source><year>2012</year><volume>327</volume><fpage>48</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2011.12.012</pub-id><pub-id pub-id-type="pmid">22182453</pub-id>
</element-citation></ref><ref id="B28-toxics-13-00073"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Iyama</surname><given-names>T.</given-names></name>
<name><surname>Wilson</surname><given-names>D.M.</given-names></name>
</person-group><article-title>DNA repair mechanisms in dividing and non-dividing cells</article-title><source>DNA Repair.</source><year>2013</year><volume>12</volume><fpage>620</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2013.04.015</pub-id><pub-id pub-id-type="pmid">23684800</pub-id>
</element-citation></ref><ref id="B29-toxics-13-00073"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kryston</surname><given-names>T.B.</given-names></name>
<name><surname>Georgieva</surname><given-names>A.B.</given-names></name>
<name><surname>Pissis</surname><given-names>P.</given-names></name>
<name><surname>Georgakilas</surname><given-names>A.G.</given-names></name>
</person-group><article-title>Role of oxidative stress and DNA damage in human carcinogenesis</article-title><source>Mutat. Res.</source><year>2011</year><volume>711</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2010.12.016</pub-id><pub-id pub-id-type="pmid">21216256</pub-id>
</element-citation></ref><ref id="B30-toxics-13-00073"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sprenger</surname><given-names>R.</given-names></name>
<name><surname>Schlagenhaufer</surname><given-names>R.</given-names></name>
<name><surname>Kerb</surname><given-names>R.</given-names></name>
<name><surname>Bruhn</surname><given-names>C.</given-names></name>
<name><surname>Brockmoller</surname><given-names>J.</given-names></name>
<name><surname>Roots</surname><given-names>I.</given-names></name>
<name><surname>Brinkmann</surname><given-names>U.</given-names></name>
</person-group><article-title>Characterization of the glutathione S-transferase GSTT1 deletion: Discrimination of all known alleles by polymerase chain reaction</article-title><source>Pharmacogenetics</source><year>2000</year><volume>10</volume><fpage>557</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1097/00008571-200008000-00009</pub-id><pub-id pub-id-type="pmid">10975610</pub-id>
</element-citation></ref><ref id="B31-toxics-13-00073"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Minina</surname><given-names>V.I.</given-names></name>
<name><surname>Soboleva</surname><given-names>O.A.</given-names></name>
<name><surname>Glushkov</surname><given-names>A.N.</given-names></name>
<name><surname>Voronina</surname><given-names>E.N.</given-names></name>
<name><surname>Sokolova</surname><given-names>E.A.</given-names></name>
<name><surname>Bakanova</surname><given-names>M.L.</given-names></name>
<name><surname>Savchenko</surname><given-names>Y.A.</given-names></name>
<name><surname>Ryzhkova</surname><given-names>A.V.</given-names></name>
<name><surname>Titov</surname><given-names>R.A.</given-names></name>
<name><surname>Druzhinin</surname><given-names>V.G.</given-names></name>
</person-group><article-title>Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients</article-title><source>J. Cancer Res. Clin. Oncol.</source><year>2017</year><volume>143</volume><fpage>2235</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.1007/s00432-017-2486-3</pub-id><pub-id pub-id-type="pmid">28770368</pub-id>
</element-citation></ref><ref id="B32-toxics-13-00073"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sal&#x02019;nikova</surname><given-names>L.</given-names></name>
<name><surname>Chumachenko</surname><given-names>A.</given-names></name>
<name><surname>Lapteva</surname><given-names>N.S.</given-names></name>
<name><surname>Vesnina</surname><given-names>I.</given-names></name>
<name><surname>Kuznetsova</surname><given-names>G.</given-names></name>
<name><surname>Rubanovich</surname><given-names>A.</given-names></name>
</person-group><article-title>Allelic variants of polymorphic genes associated with a higher frequency of chromosome aberrations</article-title><source>Russ. J. Genet.</source><year>2011</year><volume>47</volume><fpage>1364</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1134/S1022795411100152</pub-id></element-citation></ref><ref id="B33-toxics-13-00073"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ottman</surname><given-names>R.</given-names></name>
</person-group><article-title>An epidemiologic approach to gene&#x02013;environment interaction</article-title><source>Genet. Epidemiol.</source><year>1990</year><volume>7</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1002/gepi.1370070302</pub-id><pub-id pub-id-type="pmid">2369997</pub-id>
</element-citation></ref><ref id="B34-toxics-13-00073"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayes</surname><given-names>J.D.</given-names></name>
<name><surname>Pulford</surname><given-names>D.J.</given-names></name>
</person-group><article-title>The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance</article-title><source>Crit. Rev. Biochem. Mol. Biol.</source><year>1995</year><volume>30</volume><fpage>445</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.3109/10409239509083491</pub-id><pub-id pub-id-type="pmid">8770536</pub-id>
</element-citation></ref><ref id="B35-toxics-13-00073"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Doukali</surname><given-names>H.</given-names></name>
<name><surname>Najem</surname><given-names>D.</given-names></name>
<name><surname>El Messaoudi</surname><given-names>M.D.</given-names></name>
<name><surname>Bencheikh</surname><given-names>R.</given-names></name>
<name><surname>Er-Raki</surname><given-names>A.</given-names></name>
</person-group><article-title>Oxidative stress and glutathione S-transferase genetic polymorphisms in medical staff professionally exposed to ionizing radiation</article-title><source>Int. J. Radiat. Biol.</source><year>2017</year><volume>93</volume><fpage>697</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1080/09553002.2017.1305132</pub-id><pub-id pub-id-type="pmid">28287017</pub-id>
</element-citation></ref><ref id="B36-toxics-13-00073"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rotunno</surname><given-names>M.</given-names></name>
<name><surname>Lam</surname><given-names>T.K.</given-names></name>
<name><surname>Vogt</surname><given-names>A.</given-names></name>
<name><surname>Bertazzi</surname><given-names>P.A.</given-names></name>
<name><surname>Lubin</surname><given-names>J.H.</given-names></name>
<name><surname>Caporaso</surname><given-names>N.E.</given-names></name>
<name><surname>Landi</surname><given-names>M.T.</given-names></name>
</person-group><article-title>GSTM1 and GSTT1 copy numbers and mRNA expression in lung cancer</article-title><source>Mol. Carcinog.</source><year>2012</year><volume>51</volume><fpage>E142</fpage><lpage>E150</lpage><pub-id pub-id-type="doi">10.1002/mc.21890</pub-id><pub-id pub-id-type="pmid">22392686</pub-id>
</element-citation></ref><ref id="B37-toxics-13-00073"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>X.</given-names></name>
<name><surname>Tian</surname><given-names>G.</given-names></name>
<name><surname>Zhu</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>F.</given-names></name>
<name><surname>Zhang</surname><given-names>R.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>An</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Song</surname><given-names>J.</given-names></name>
<name><surname>Jiang</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Air pollution associated acute respiratory inflammation and modification by GSTM1 and GSTT1 gene polymorphisms: A panel study of healthy undergraduates</article-title><source>Environ. Health</source><year>2023</year><volume>22</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1186/s12940-022-00954-9</pub-id><pub-id pub-id-type="pmid">36703205</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxics-13-00073-f001"><label>Figure 1</label><caption><p>Frequency of chromatid-type and chromosome-type CAs according to GSTM1 and GSTT1 copy numbers in controls and relatively low- and high-exposure worker groups.</p></caption><graphic xlink:href="toxics-13-00073-g001" position="float"/></fig><fig position="float" id="toxics-13-00073-f002"><label>Figure 2</label><caption><p>Interaction between GST copy number and radiation exposure in the occurrence of chromatid-type aberrations; *, <italic toggle="yes">p</italic> &#x0003c; 0.05 compared to the reference (for which the relative frequency ratio is 1.0).</p></caption><graphic xlink:href="toxics-13-00073-g002" position="float"/></fig><table-wrap position="float" id="toxics-13-00073-t001"><object-id pub-id-type="pii">toxics-13-00073-t001_Table 1</object-id><label>Table 1</label><caption><p>General characteristics of study population.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Variables</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">No. of Subjects (%)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Controls</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Workers</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Number</td><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">180</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (mean &#x000b1; SD, years)</td><td align="center" valign="middle" rowspan="1" colspan="1">40.9 &#x000b1; 10.0</td><td align="center" valign="middle" rowspan="1" colspan="1">47.5 &#x000b1; 5.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01 <sup>a</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02264;50</td><td align="center" valign="middle" rowspan="1" colspan="1">36 (80)</td><td align="center" valign="middle" rowspan="1" colspan="1">117 (65)</td><td rowspan="2" align="center" valign="middle" colspan="1">0.05 <sup>b</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02003;&#x0003e;50</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (20)</td><td align="center" valign="middle" rowspan="1" colspan="1">63 (35)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Smoking status (mean &#x000b1; SD, pack-years)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.6 &#x000b1; 13.5</td><td align="center" valign="middle" rowspan="1" colspan="1">12.6 &#x000b1; 11.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.52 <sup>a</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Current smoking </td><td align="center" valign="middle" rowspan="1" colspan="1">20 (44.4) </td><td align="center" valign="middle" rowspan="1" colspan="1">69 (38.3)</td><td rowspan="2" align="center" valign="middle" colspan="1">0.45 <sup>b</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Never smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (55.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (18.3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Alcohol intake</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (66.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">147 (81.7)</td><td rowspan="2" align="center" valign="middle" colspan="1">0.03 <sup>b</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (33.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (18.3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Duration of employment (mean &#x000b1; SD, years)</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">20.1 &#x000b1; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02264;20</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">103 (45.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003e;20</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">122 (54.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dosimetry radiation dose</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Recent 1.5-year (mean &#x000b1; SD, mSv)</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">8.2 &#x000b1; 7.1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02003;Cumulative dose (mean &#x000b1; SD, mSv)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">157.3 &#x000b1; 85.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>SD, Standard deviation. <sup>a</sup> Determined by Mann&#x02013;Whitney U-test. <sup>b</sup> Determined by <italic toggle="yes">x</italic><sup>2</sup> test.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00073-t002"><object-id pub-id-type="pii">toxics-13-00073-t002_Table 2</object-id><label>Table 2</label><caption><p>Frequencies of chromosomal aberrations in nuclear power plant workers and controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Types of Chromosome Aberration</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Controls</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Radiation Exposed Workers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean/<break/>500 Cells</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Range</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean/<break/>500 Cells</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SD</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Range</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value *</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Number</td><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">180</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chromatid-type deletion</td><td align="center" valign="middle" rowspan="1" colspan="1">3.53</td><td align="center" valign="middle" rowspan="1" colspan="1">2.21</td><td align="center" valign="middle" rowspan="1" colspan="1">0- 10</td><td align="center" valign="middle" rowspan="1" colspan="1">5.41</td><td align="center" valign="middle" rowspan="1" colspan="1">2.76</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;17</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chromatid-type exchange</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7697</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chromosome-type deletion</td><td align="center" valign="middle" rowspan="1" colspan="1">0.51</td><td align="center" valign="middle" rowspan="1" colspan="1">0.82</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;3</td><td align="center" valign="middle" rowspan="1" colspan="1">2.08</td><td align="center" valign="middle" rowspan="1" colspan="1">1.98</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;14</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Chromosome-exchange</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total aberration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.51</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>SD, standard deviation. * determined by Mann&#x02013;Whitney U-test.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00073-t003"><object-id pub-id-type="pii">toxics-13-00073-t003_Table 3</object-id><label>Table 3</label><caption><p>Distribution of GSTM1 and GSTT1 copy number in radiation-exposed workers and controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Copy Number</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Controls, N (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Exposed, N (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value *</th></tr><tr><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No. of Subjects</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td rowspan="8" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">GSTM1</td><td align="center" valign="middle" rowspan="1" colspan="1">0 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">25 (55.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">89 (49.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">17 (37.38)</td><td align="center" valign="middle" rowspan="1" colspan="1">72 (40.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">3 (6.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (9.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.00)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (55.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">89 (49.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (44.44)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91 (50.56)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">0 or 1</td><td align="center" valign="middle" rowspan="1" colspan="1">42 (93.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">161 (89.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (6.67)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (10.56)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="7" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">GSTT1</td><td align="center" valign="middle" rowspan="1" colspan="1">0 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">24 (53.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (48.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.75</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">16 (35.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">75 (41.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (11.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (9.44)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">24 (53.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (48.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (49.67)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92 (51.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">0 or 1</td><td align="center" valign="middle" rowspan="1" colspan="1">40 (88.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">163 (90.56)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.74</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (11.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (9.44)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>* The difference in copy numbers between radiation-exposed workers and controls, <italic toggle="yes">x</italic><sup>2</sup> test. <sup>a</sup>, (0/0) Homozygous deletion (null genotype). <sup>b</sup>, (0/1) Hemizygous deletion. <sup>c</sup>, (1/1) Wild-type (positive genotype, two functional genes).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00073-t004"><object-id pub-id-type="pii">toxics-13-00073-t004_Table 4</object-id><label>Table 4</label><caption><p>Frequency of chromosome aberrations (CAs) in radiation-exposed workers and controls according to GSTM1 and GSTT1 copy numbers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Copy <break/>Number</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Controls</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Exposure Group</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CA &#x000b1; SD</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CA &#x000b1; SD</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">GSTM1</td><td align="left" valign="middle" rowspan="1" colspan="1">0 <sup>i</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">4.04 &#x000b1; 2.76</td><td align="left" valign="middle" rowspan="1" colspan="1">0.75 <sup>a</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">89</td><td align="center" valign="middle" rowspan="1" colspan="1">8.97 &#x000b1; 3.50</td><td align="left" valign="middle" rowspan="1" colspan="1">0.04 <sup>a</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 <sup>ii</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">4.29 &#x000b1; 2.28</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">72</td><td align="center" valign="middle" rowspan="1" colspan="1">7.75 &#x000b1; 3.62</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2+ <sup>iii</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.33 &#x000b1; 2.08</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">8.16 &#x000b1; 3.04</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">0 or 1</td><td align="left" valign="middle" rowspan="1" colspan="1">42</td><td align="center" valign="middle" rowspan="1" colspan="1">4.41 &#x000b1; 2.55</td><td align="left" valign="middle" rowspan="1" colspan="1">0.65 <sup>b</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">161</td><td align="center" valign="middle" rowspan="1" colspan="1">8.42 &#x000b1; 3.59</td><td align="left" valign="middle" rowspan="1" colspan="1">0.95 <sup>b</sup></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2+</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.33 &#x000b1; 2.08</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.16 &#x000b1; 3.04</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="4" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">GSTT1</td><td align="left" valign="middle" rowspan="1" colspan="1">0 <sup>i</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">3.50 &#x000b1; 2.73</td><td align="left" valign="middle" rowspan="1" colspan="1">0.07 <sup>a</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">88</td><td align="center" valign="middle" rowspan="1" colspan="1">8.22 &#x000b1; 3.35</td><td align="left" valign="middle" rowspan="1" colspan="1">0.43 <sup>a</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 <sup>ii</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">4.81 &#x000b1; 2.20</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">75</td><td align="center" valign="middle" rowspan="1" colspan="1">8.75 &#x000b1; 3.46</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2 <sup>iii</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">4.60 &#x000b1; 1.95</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">7.76 &#x000b1; 4.70</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="2" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">0 or 1</td><td align="left" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">4.03 &#x000b1; 2.59</td><td align="left" valign="middle" rowspan="1" colspan="1">0.44 <sup>b</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">163</td><td align="center" valign="middle" rowspan="1" colspan="1">8.46 &#x000b1; 3.40</td><td align="left" valign="middle" rowspan="1" colspan="1">0.38 <sup>b</sup>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2+</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.60 &#x000b1; 1.95</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.76 &#x000b1; 4.70</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>CA, chromosome aberration frequency per 500 cells. SD, standard deviation. <sup>a</sup>, Tested by Kruskal&#x02013;Wallis Test. <sup>b</sup>, Tested by Mann&#x02013;Whitney U-test; <sup>i</sup> (0/0), homozygous deletion (null genotype); <sup>ii</sup> (0/1), hemizygous deletion. <sup>iii</sup> (1/1), Wild-type (positive genotype, two functional genes).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00073-t005"><object-id pub-id-type="pii">toxics-13-00073-t005_Table 5</object-id><label>Table 5</label><caption><p>Poisson regression analysis of chromosome aberrations (CAs): effects of GSTM1 and GSTT1 copy number and radiation exposure in the relatively highly exposed group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Copy<break/>Number</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Total Chromosome Aberration</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Chromosome-Type Aberration </th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Chromatid-Type Aberration </th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FR <sup>a</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">GSTM1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">reference</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">reference</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">reference</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87</td><td align="center" valign="middle" rowspan="1" colspan="1">0.75 1.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">0.92</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72 1.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64 0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.66 1.09</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.68 1.47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.51 0.98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">GSTT1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">reference</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">reference</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">reference</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97</td><td align="center" valign="middle" rowspan="1" colspan="1">0.83 1.12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97</td><td align="center" valign="middle" rowspan="1" colspan="1">0.75 1.24</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79</td><td align="center" valign="middle" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77 1.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.48</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.69 1.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.79 1.69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.49 0.99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.05</td></tr></tbody></table><table-wrap-foot><fn><p>Relatively high-exposure group. (Recent 1&#x02013;5 yr dose, &#x02265;7.5 mSv; <italic toggle="yes">n</italic> = 91/180). <sup>a</sup>, Frequency ratio adjusted for age, smoking status, and alcohol intake.</p></fn></table-wrap-foot></table-wrap></floats-group></article>